-
Nasal bone in first-trimester screening for trisomy 21.
Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH.
Am J Obstet Gynecol 2006;195:109-14. -
Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study.
Chitty LS, Kagan KO, Molina FS, Waters JJ, Nicolaides KH.
BMJ 2006;332:452-5. -
Aneuploidy screening in a coelomic sample from a missed abortion using sequential fluorescence in situ hybridization.
Chatzimeletiou K, Makrydimas G, Nicolaides KH.
Fertil Steril 2006;85:1059. -
Hypermethylated RASSF1A in Maternal Plasma: A Universal Fetal DNA Marker that Improves the Reliability of Noninvasive Prenatal Diagnosis.
Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM.
Clin Chem 2006;52:2211-8. -
Brachycephaly and frontal lobe hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Dagklis T, Csapo B, Sotiriadis A, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;28:870-5. -
Maternal cardiac function in fetal growth restriction.
Bamfo JE, Kametas NA, Turan O, Khaw A, Nicolaides KH.
BJOG 2006;113:784-91. -
Cervical assessment at the routine 23-weeks' scan: problems with transabdominal sonography.
To MS, Skentou C, Cicero S, Nicolaides KH.
Ultrasound Obstet Gynecol 2000;15:292-6. -
First trimester markers of trisomy 21 and the influence of maternal cigarette smoking status.
Spencer K, Ong CYT, Liao AWJ, Papademetriou D, Nicolaides KH.
Prenat Diagn 2000;20:852-3. -
The influence of parity and gravidity on first trimester markers of chromosomal abnormality.
Spencer K, Ong CYT, Liao AWJ, Papademetriou D, Nicolaides KH.
Prenat Diagn 2000;20:792-4. -
First trimester prenatal diagnosis of trisomy 21 in discordant twins using fetal nuchal translucency thickness and maternal serum free beta-hCG and PAPP-A.
Spencer K, Nicolaides KH.
Prenat Diagn 2000;20:683-4. -
The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolaides KH.
Prenat Diagn 2000;20:673-5. -
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
Spencer K, Heath V, Flack N, Ong C, Nicolaides KH.
Prenat Diagn 2000;20:635-9. -
Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Liao AW, Skentou H, Cicero S, Nicolaides KH.
Prenat Diagn 2000;20:495-9. -
The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities.
Spencer K, Ong CY, Liao AW, Nicolaides KH.
Prenat Diagn 2000;20:491-4. -
Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH.
Prenat Diagn 2000;20:411-6. -
Maternal serum free beta-hCG and PAPP-A in fetal sex chromosome defects in the first trimester.
Spencer K, Tul N, Nicolaides KH.
Prenat Diagn 2000;20:390-4. -
Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?
Spencer K, Berry E, Crossley JA, Aitken DA, Nicolaides KH.
Prenat Diagn 2000;20:311-7. -
One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester.
Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH.
BJOG 2000;107:1271-5. -
Trophoblast proliferation is increased in chorionic villi from pregnancies with fetal trisomy 18.
Sebire NJ, Fowler D, Roberts L, Mahmood S, Nicolaides KH.
Placenta 2000;21:584-6. -
Semiquantitative immunohistochemical localisation of PAPP-A and beta-hCG in first trimester chorionic villi from euploid and trisomic pregnancies.
Sebire NJ, Roberts L, Nicolaides KH.
J Pathol 2000;192:30.